MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,529 | -14.0% | 88,311 | -1.2% | 0.00% | – |
| Q2 2023 | $478,317 | -50.1% | 89,405 | -33.2% | 0.00% | – |
| Q1 2023 | $959,302 | +1586.5% | 133,794 | +1478.3% | 0.00% | – |
| Q4 2022 | $56,881 | -92.9% | 8,477 | -96.3% | 0.00% | – |
| Q3 2022 | $802,000 | -31.5% | 231,756 | -41.6% | 0.00% | – |
| Q2 2022 | $1,170,000 | -84.8% | 396,749 | -54.6% | 0.00% | -100.0% |
| Q1 2022 | $7,697,000 | -61.6% | 873,688 | -30.1% | 0.00% | 0.0% |
| Q4 2021 | $20,070,000 | -41.9% | 1,250,481 | -24.2% | 0.00% | -66.7% |
| Q3 2021 | $34,530,000 | -32.5% | 1,649,035 | -13.4% | 0.00% | -25.0% |
| Q2 2021 | $51,138,000 | -14.0% | 1,903,871 | +2.0% | 0.00% | -20.0% |
| Q1 2021 | $59,433,000 | +114.5% | 1,866,060 | +53.9% | 0.01% | +150.0% |
| Q4 2020 | $27,714,000 | -6.4% | 1,212,322 | +3.1% | 0.00% | -33.3% |
| Q3 2020 | $29,607,000 | +119.4% | 1,175,340 | +143.2% | 0.00% | +200.0% |
| Q2 2020 | $13,495,000 | +298.4% | 483,352 | -17.0% | 0.00% | – |
| Q1 2020 | $3,387,000 | -62.5% | 582,043 | -29.9% | 0.00% | -100.0% |
| Q4 2019 | $9,035,000 | -35.5% | 830,443 | -24.3% | 0.00% | -50.0% |
| Q3 2019 | $14,005,000 | -35.7% | 1,097,543 | -14.4% | 0.00% | -33.3% |
| Q2 2019 | $21,765,000 | -22.3% | 1,282,543 | -17.7% | 0.00% | 0.0% |
| Q1 2019 | $28,008,000 | +6.9% | 1,557,731 | -24.5% | 0.00% | -25.0% |
| Q4 2018 | $26,195,000 | -53.4% | 2,062,631 | -21.3% | 0.00% | -33.3% |
| Q3 2018 | $56,177,000 | -10.5% | 2,620,211 | -13.8% | 0.01% | -14.3% |
| Q2 2018 | $62,801,000 | -26.8% | 3,041,194 | -10.8% | 0.01% | -30.0% |
| Q1 2018 | $85,822,000 | +24.1% | 3,411,035 | -6.3% | 0.01% | +25.0% |
| Q4 2017 | $69,151,000 | -15.0% | 3,639,537 | -17.4% | 0.01% | -20.0% |
| Q3 2017 | $81,396,000 | -11.3% | 4,404,524 | -15.9% | 0.01% | -9.1% |
| Q2 2017 | $91,733,000 | -0.2% | 5,238,917 | +6.0% | 0.01% | -8.3% |
| Q1 2017 | $91,947,000 | -13.9% | 4,943,364 | -5.4% | 0.01% | -14.3% |
| Q4 2016 | $106,806,000 | -28.2% | 5,225,358 | +5.0% | 0.01% | -30.0% |
| Q3 2016 | $148,827,000 | +10.8% | 4,975,827 | -0.0% | 0.02% | +11.1% |
| Q2 2016 | $134,356,000 | +102.4% | 4,977,997 | +40.6% | 0.02% | +100.0% |
| Q1 2016 | $66,372,000 | -40.6% | 3,539,822 | -1.8% | 0.01% | -40.0% |
| Q4 2015 | $111,654,000 | +49.4% | 3,605,231 | +3.3% | 0.02% | +36.4% |
| Q3 2015 | $74,736,000 | -38.7% | 3,489,082 | +8.6% | 0.01% | -31.2% |
| Q2 2015 | $121,961,000 | +21.0% | 3,212,042 | 0.0% | 0.02% | +23.1% |
| Q1 2015 | $100,762,000 | -10.5% | 3,212,042 | 0.0% | 0.01% | -13.3% |
| Q4 2014 | $112,646,000 | +67.8% | 3,212,042 | 0.0% | 0.02% | +66.7% |
| Q3 2014 | $67,132,000 | -5.3% | 3,212,042 | -1.5% | 0.01% | 0.0% |
| Q2 2014 | $70,852,000 | +29.9% | 3,260,568 | +66.4% | 0.01% | +12.5% |
| Q1 2014 | $54,539,000 | +65.7% | 1,959,742 | +63.3% | 0.01% | +60.0% |
| Q4 2013 | $32,916,000 | – | 1,200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |